Nilotinib Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Condition:   CML, Chronic Phase; TKI Interventions:   Drug: Flumatinib Mesylate;   Drug: Nilotinib Pill Sponsor:   The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2021 Category: Research Source Type: clinical trials